1.
Sung-Hyun Kim, Dong-Wook Kim. Comment on “Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors”. haematol [Internet]. 2015Mar.1 [cited 2022Nov.30];100(3):e120-e121. Available from: https://haematologica.org/article/view/7320